Watanabe O
Department of Surgery, Tokyo Women's Medical College Daini Hospital.
Nihon Geka Gakkai Zasshi. 1994 Apr;95(4):263-70.
The antitumor effect of combined chemoendocrine therapy with tamoxifen (TAM) and 5-fluorouracil (5-FU) on breast carcinoma xenograft (R-27), serially transplanted into the nude mice, was examined from the aspect of estrogen receptors (ER) and cytological features. The mice were given 6 intramuscular injections of TAM (5mg/kg) at 3-day intervals (TAM group), 3 intraperitoneal injections of 5-FU (60 mg/kg) at 4-day intervals ((5-FU group), or a combination of the two drugs (combined group). When the tumor was resected on 21 days after the initial treatment, the ER were assayed and %S was determined by flowcytometry. Furthermore, proliferative cell nuclear antigen (PCNA) was stained, and the stained cells were counted. A synergistic antitumor effect of TAN and 5-FU was found in mice given combined therapy. Reduction in the ER level was more marked in this group than in the others, but there were no significant differences in the %S value or the ratio of PCNA positive cells among the three treated groups. These results suggest that the combined effect of TAM and 5-FU has no relation to the inhibition of DNA synthesis.
从雌激素受体(ER)和细胞学特征方面,研究了他莫昔芬(TAM)与5-氟尿嘧啶(5-FU)联合化学内分泌疗法对连续移植到裸鼠体内的乳腺癌异种移植瘤(R-27)的抗肿瘤作用。给小鼠每隔3天进行6次肌肉注射TAM(5mg/kg)(TAM组),每隔4天进行3次腹腔注射5-FU(60mg/kg)(5-FU组),或两种药物联合使用(联合组)。在初始治疗后21天切除肿瘤时,检测ER并通过流式细胞术测定%S。此外,对增殖细胞核抗原(PCNA)进行染色,并对染色细胞进行计数。在接受联合治疗的小鼠中发现TAM和5-FU具有协同抗肿瘤作用。该组中ER水平的降低比其他组更明显,但三个治疗组之间的%S值或PCNA阳性细胞比例没有显著差异。这些结果表明,TAM和5-FU的联合作用与DNA合成的抑制无关。